Biogen Is ‘Evaluating Strategic Options’ For Its Biosimilars Business

CEO Says ‘Formal Process Is Underway’ To Consider Selling To A New Owner

 
• By Dave Wallace

Biogen revealed that a formal process is now underway to “evaluate strategic options” for its biosimilars business, pointing to a potential transfer of the unit to a new owner.

Sell decision - yes or no? Wooden blocks
Biogen is weighing whether to sell its biosimilars business • Source: Shutterstock

More from Biosimilars

More from Products